차세대 콘택트렌즈 및 시각 보철물 시장 : 디바이스 유형, 장착 기간, 재료, 연령층, 용도, 유통 채널, 최종 사용자별 예측(2026-2032년)

The Next Generation Contact Lenses & Visual Prostheses Market is projected to grow by USD 1,045.77 million at a CAGR of 19.29% by 2032.

Executive Introduction of Next-Generation Contact Lenses and Visual Prostheses

Next-generation contact lenses and visual prostheses are moving from conventional vision correction toward therapeutic, digital, and restorative eye-care platforms. The category includes myopia-control lenses, drug-eluting contact lenses, scleral and specialty lenses, smart sensor-enabled lenses, retinal implants, cortical vision prostheses, and noninvasive visual substitution systems.

The market is supported by measurable clinical need. The World Health Organization estimates that at least 2.2 billion people live with near or distance vision impairment, and at least 1 billion cases are preventable or not yet addressed. Rising myopia, diabetes-related retinal disease, aging populations, and demand for personalized eye care are making advanced contact lenses and visual prostheses a strategic priority for medtech, ophthalmology, optometry, and digital health leaders.

Transformative Shifts in the Landscape

The landscape is shifting from passive optical devices to clinically validated platforms that combine materials science, electronics, drug delivery, and data analytics. Regulatory approval of a ketotifen-eluting contact lens in 2022 demonstrated that contact lenses can deliver ophthalmic medication, while myopia-management lenses and orthokeratology are expanding the role of lenses in long-term disease-risk reduction.

Visual prostheses are undergoing a parallel transition. Earlier retinal implants proved that artificial vision can be restored in selected patients with profound retinal degeneration, but the field is now emphasizing higher-resolution stimulation, more durable hardware, improved surgical workflows, and brain-computer interface approaches. The strongest commercial opportunities will come from solutions that show durable clinical benefit, manageable cost, and clear reimbursement logic.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a force multiplier across next-generation contact lenses and visual prostheses. In contact lenses, AI supports customized lens fitting, corneal topography interpretation, manufacturing quality control, adverse-event monitoring, and patient adherence analytics. These uses align with broader ophthalmology adoption of AI, including regulator-authorized autonomous diabetic retinopathy screening systems.

In visual prostheses, AI can improve image preprocessing, edge detection, object recognition, scene simplification, and adaptive stimulation strategies. This is critical because prosthetic vision remains limited compared with natural sight. AI-enabled software can convert complex visual scenes into more usable signals, making prosthetic devices more functional for mobility, orientation, and daily living.

Key Regional Insights: Asia-Pacific, North America, Europe, and Emerging Regions

Asia-Pacific is the largest strategic demand center because myopia prevalence is exceptionally high in East and Southeast Asia, where studies have reported myopia rates of roughly 80% to 90% among young adults in some urban populations. Japan, China, South Korea, Singapore, and Australia also combine strong ophthalmic research, specialty lens adoption, and advanced electronics supply chains, supporting innovation in smart contact lenses, myopia-control products, and visual prosthesis components.

North America leads in regulatory precedent, venture funding, clinical trials, and authorized ophthalmic innovation, while Europe benefits from established eye-care infrastructure and rigorous medical-device governance under the EU Medical Device Regulation. Latin America is a long-term access market shaped by urbanization, private eye-care expansion, and diabetes-related retinal disease. The Middle East, particularly higher-income Gulf markets, is supported by diabetes care investment and premium ophthalmology services, while Africa has substantial unmet need in refractive correction, corneal disease, cataract-linked visual burden, and low-vision rehabilitation, with affordability and specialist availability remaining key constraints.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN is positioned as both a demand and manufacturing corridor, supported by rising urban myopia, expanding optical retail networks, and competitive medical-device production capabilities across several member economies. The GCC is a high-value market for advanced eye care because diabetes prevalence and public-sector health investment are both significant, creating demand for retinal disease management, premium ophthalmology technologies, and specialized low-vision services.

The European Union offers scale through harmonized market access pathways but requires strong clinical evidence, quality management, and post-market surveillance under medical-device rules. BRICS countries contribute large patient populations, growing domestic medtech capacity, and substantial unmet refractive and retinal care needs, while the G7 remains central to R&D, reimbursement models, clinical validation, and early adoption of high-complexity devices. NATO markets add relevance through defense medicine, trauma rehabilitation, and neuroprosthetics research that can overlap with visual restoration technologies.

Key Country Insights Across Major Ophthalmology Markets

The United States is the leading commercialization hub due to regulatory pathways, venture capital, academic ophthalmology centers, and early adoption of digital health. Canada supports specialty lens and low-vision care through strong clinical networks, while Mexico and Brazil offer growth potential through large urban populations, expanding private eye-care markets, and rising diabetes-related retinal disease burden.

In Europe, the United Kingdom, Germany, France, Italy, and Spain are important for clinical validation, specialty lens adoption, ophthalmology research, and medical-device procurement, while Russia represents a more complex market shaped by access, supply-chain, and geopolitical constraints. In Asia-Pacific, China and India provide the largest volume opportunities due to population scale and growing eye-care demand, Japan and South Korea contribute advanced electronics, precision manufacturing, and clinical innovation, and Australia is a strong market for myopia management, optometry-led care, and specialty contact lens research.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence generation, not feature expansion alone. Products should be designed around measurable endpoints such as myopia progression reduction, ocular allergy symptom relief, corneal health, mobility improvement, visual acuity, patient-reported outcomes, device durability, and safety.

Commercial strategies should pair premium innovation with scalable access models. Organizations should invest in clinician training, AI-supported fitting tools, regulatory-grade data infrastructure, payer evidence, and partnerships with ophthalmology networks, optometry groups, universities, and rehabilitation centers.

Research Methodology

Research methodology is grounded in publicly verifiable evidence from global health agencies, regulatory precedents, peer-reviewed ophthalmology research, and established medtech market dynamics. Key data anchors include WHO estimates on vision impairment, documented high myopia prevalence in East Asia, regulatory approvals in ophthalmic drug delivery and AI screening, and known regulatory frameworks such as the EU Medical Device Regulation.

The methodology emphasizes triangulation across clinical need, technology readiness, regulatory acceptance, reimbursement feasibility, and regional adoption capacity. Market interpretation excludes unsupported numerical forecasts and focuses on validated demand drivers, documented clinical milestones, disease-burden evidence, and observable commercialization trends.

Conclusion

Next-generation contact lenses and visual prostheses are becoming a high-impact frontier in ophthalmology, combining optical correction, therapy, diagnostics, digital intelligence, and neural restoration. The sector is shaped by rising myopia, aging populations, diabetes-related retinal disease, and the unmet needs of people with severe vision loss.

The strongest opportunities will belong to organizations that prove clinical value, integrate AI responsibly, meet regulatory expectations, and build practical access pathways. As devices become smarter, more personalized, and more restorative, this category is positioned to redefine how vision care is delivered worldwide.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Next Generation Contact Lenses & Visual Prostheses Market, by Device Type

• 7.1. Contact Lenses
  • 7.1.1. Hybrid Lenses
  • 7.1.2. Rigid Gas Permeable
  • 7.1.3. Soft Lenses
    • 7.1.3.1. Daily Disposable
    • 7.1.3.2. Extended Wear
    • 7.1.3.3. Monthly Disposable
• 7.2. Visual Prostheses
  • 7.2.1. Cortical Implant
  • 7.2.2. Optic Nerve Implant
  • 7.2.3. Retinal Implant
    • 7.2.3.1. Epiretinal Implant
    • 7.2.3.2. Subretinal Implant

8. Next Generation Contact Lenses & Visual Prostheses Market, by Wear Duration

• 8.1. Daily Disposable
• 8.2. Extended Wear
• 8.3. Monthly Disposable

9. Next Generation Contact Lenses & Visual Prostheses Market, by Material

• 9.1. Conventional Hydrogel
• 9.2. Hybrid Polymer
• 9.3. Polymethyl Methacrylate
• 9.4. Silicone Hydrogel

10. Next Generation Contact Lenses & Visual Prostheses Market, by Age Group

• 10.1. Adults
• 10.2. Children
• 10.3. Seniors

11. Next Generation Contact Lenses & Visual Prostheses Market, by Application

• 11.1. Astigmatism Correction
• 11.2. Cosmetic Enhancement
• 11.3. Myopia Control
• 11.4. Presbyopia Correction
• 11.5. Therapeutic Treatment

12. Next Generation Contact Lenses & Visual Prostheses Market, by Distribution Channel

• 12.1. Offline
• 12.2. Online

13. Next Generation Contact Lenses & Visual Prostheses Market, by End User

• 13.1. Ambulatory Surgery Centers
• 13.2. Home Healthcare
• 13.3. Hospitals
• 13.4. Specialty Clinics

14. Next Generation Contact Lenses & Visual Prostheses Market, by Region

• 14.1. Asia-Pacific
• 14.2. North America
• 14.3. Latin America
• 14.4. Europe
• 14.5. Middle East
• 14.6. Africa

15. Next Generation Contact Lenses & Visual Prostheses Market, by Group

• 15.1. ASEAN
• 15.2. GCC
• 15.3. European Union
• 15.4. BRICS
• 15.5. G7
• 15.6. NATO

16. Next Generation Contact Lenses & Visual Prostheses Market, by Country

• 16.1. United States
• 16.2. Canada
• 16.3. Mexico
• 16.4. Brazil
• 16.5. United Kingdom
• 16.6. Germany
• 16.7. France
• 16.8. Russia
• 16.9. Italy
• 16.10. Spain
• 16.11. China
• 16.12. India
• 16.13. Japan
• 16.14. Australia
• 16.15. South Korea

17. Competitive Landscape

• 17.1. Market Concentration Analysis, 2025
  • 17.1.1. Concentration Ratio (CR)
  • 17.1.2. Herfindahl Hirschman Index (HHI)
• 17.2. Recent Developments & Impact Analysis, 2025
• 17.3. Product Portfolio Analysis, 2025
• 17.4. Benchmarking Analysis, 2025

18. Company Profiles

• 18.1. Abbott Laboratories
• 18.2. Alcon Inc.
• 18.3. Bausch + Lomb Corporation
• 18.4. Bionic Sight LLC
• 18.5. Bionic Vision Technologies Pty Ltd
• 18.6. Canon Inc.
• 18.7. Carl Zeiss Meditec AG
• 18.8. CooperVision, Inc.
• 18.9. Cortigent Inc.
• 18.10. EssilorLuxottica S.A.
• 18.11. EyePrint Prosthetics LLC
• 18.12. EyeYon Medical Ltd.
• 18.13. HOYA Corporation
• 18.14. Implandata Ophthalmic Products GmbH
• 18.15. Interojo Co., Ltd.
• 18.16. Johnson & Johnson Vision Care, Inc.
• 18.17. LUMEDICA Corporation
• 18.18. Menicon Co., Ltd.
• 18.19. Mojo Vision Inc.
• 18.20. Nano Retina Ltd.
• 18.21. NIDEK Co., Ltd.
• 18.22. Novartis AG
• 18.23. Optobionics Corporation
• 18.24. OrCam Technologies Ltd.
• 18.25. Pixium Vision SA
• 18.26. Retina Implant AG
• 18.27. Science Corporation
• 18.28. Second Sight Medical Products, Inc.
• 18.29. SEED Co., Ltd.
• 18.30. SENSIMED SA
• 18.31. STAAR Surgical Company
• 18.32. SynergEyes, Inc.
• 18.33. Topcon Corporation
• 18.34. XPANCEO Research on Natural Science L.L.C.